Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - Pharmaceutical News - AbbVie stirs safety jitters after two patients die in ABT-494 study [Arab Finance (Egypt)] - November 20, 2017

Pharmacy News Article

 9/12/17 - AbbVie stirs safety jitters after two patients die in ABT-494 study [Arab Finance (Egypt)]

AbbVie $ABBV revealed that two rheumatoid arthritis patients died in its late-stage work on ABT-494, which quickly triggered a case of the jitters for a drug touted as a major part of the companys late-stage pipeline hopes.

According to researchers, the two patient deaths include one for unknown causes. A second patient in the 30 mg dose group came down with a fever and had problems with diarrhea. The subject subsequently experienced heart failure and presumed pulmonary embolism.

AbbVie had focused hard on the positive efficacy data for this drug, now through two Phase III trials. The drug hit all major endpoints in this new study. The therapy is now dubbed upadacitinib.

AbbVies shares took a hit on the news, dropping 1.2% after the market opened.

Just a few days ago AbbVie was touting stellar data for this drug in atopic dermatitis, which helped explain why it decided to take a pass on some big partnership deals to concentrate on its in-house program.

We are very pleased with the positive results for upadacitinib in the SELECT-BEYOND trial. Particularly exciting is the proportion of patients who achieved clinical remission by week 12 and 24, despite having inadequate responses with previous biologic therapies, said Michael Severino, Abbvies chief scientific officer.

(c) 2017 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Nov 20: Obesity Management: Overview of Pharmacotherapy
Last Chance
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement